Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$66.02 - $79.71 $277,284 - $334,782
4,200 Added 350.0%
5,400 $429,000
Q3 2021

Nov 12, 2021

BUY
$68.67 - $84.02 $82,404 - $100,824
1,200 New
1,200 $83,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Lumina Fund Management LLC Portfolio

Follow Lumina Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lumina Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lumina Fund Management LLC with notifications on news.